1. Asarnow RF, Granholm E, Sherman T. Span of apprehension in schizophrenia. In: Steinhauer SR, Gruzelier JH, Zubin J, eds. Handbook of schizophrenia, Vol. 5, Neuropsychology, psychophysiology and information processing. New York: Elsevier; 1991.

2. Berman KF, Torrey EF, Daniel DG, Weinberger DR. Regional cortical blood flow in monozygotic twins discordant and concordant for schizophrenia. Arch Gen Psychiatry 1992;49:927–934.

3. Bilder RM, Goldberg E. Motor perseveration in schizophrenia. Arch Clin Neuropsychol 1987;2:195–214.

4. Bilder RM, Lieberman JA, Kim Y, Alvir JA, Reiter G. Methylphenidate and neuroleptic effects on oral word production in schizophrenia. Neuropsychiatry Neuropsychol Behav Neurol 1992;5:262–271.

5. Bilder RM, Lipschutz-Broch L, Reiter G, Geisler S, Mayerhoff D, Lieberman JA. Intellectual deficits in first episode and chronic schizophrenia: evidence for progressive deterioration? Schiz Bull [in press].

6. Braff DL, Heaton R, Kuck J, et al. The generalized pattern of neuropsychological deficits in outpatients with chronic schizophrenia with heterogeneous Wisconsin Card Sorting Test results. Arch Gen Psychiatry 1991;48:891–898.

7. Braff DL, Saccuzzo DP, Geyer MA. Information processing dysfunctions in schizophrenia: studies of visual backward masking, sensorimotor gating, and habituation. In: Steinhauer SR, Gruzelier JH, Zubin J, eds. Neuropsychology, Psychophysiology and Information Processing. New York: Elsevier; 1991:303–334. (Handbook of schizophrenia, vol. 5).

8. Calev A. Recall and recognition in mildly disturbed schizophrenics: the use of matched tasks. Psychol Med 1984;14:425–429.

9. Cohen JD, Servan-Schreiber D. Context, cortex and dopamine: a connectionistic approach to behavior and biology in schizophrenia. Psychol Rev 1992;99:45–77.

10. Cornblatt RA, Erlenmeyer-Kimling L. Global attentional deviance as a marker of risk for schizophrenia: specificity and predictive validity. J Abnorm Psychol 1985;96:470–486.

11. Daniel DG, Goldberg TE, Gibbon R, Weinberger DR. Lack of a bimodal distribution of ventricular size in schizophrenia: a Gaussian mixture analysis of 1056 cases and controls. Biol Psychiatry 1991;30:887–903.

12. Daniel DG, Weinberger DR, Jones DW, et al. The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia. J Neurosci 1991;11:1907–1917.

13. Davidson M, Powchik P, Losonczy MF, et al. Dementia in elderly schizophrenic patients clinical and neuropathological correlates. Biol Psychiatry 1991;29:91A.

14. Faustman WO, Moses JA Jr, Csernansky JB. Neuropsychological performance and symptomatology: Correlations in medicated and unmedicated schizophrenic patients. Psychiatry Res [in press].

15. Fey ET. The performance of young schizophrenics and young normals on the Wisconsin Card Sorting Test. J Consult Psychol 1951;15:311–319.

16. Fields RB, Van Kammen DP, Peters JL, et al. Clonidine improves memory function in schizophrenia independently from change in psychosis: Preliminary findings. Schizophr Res 1988;1:417–423.

17. Fleming K, Goldberg TE, Gold JM, Weinberger DR. Brown Peterson performance in patients with schizophrenia. Psychiatr Res [in press].

18. Frith C. The cognitive neuropsychology of schizophrenia. Hove, UK: Lawrence Erlbaum Associates, Publishers; 1993.

19. Gold JM, Goldberg TE, Kleinman JE, Weinberger DR. The impact of symptomatic state and pharmacological treatment on cognitive functioning of patients with schizophrenia and mood disorders. In: Mohr E, Brouwers P eds. Handbook of clinical trials. The neurobehavioral and injury. Amsterdam: Swets and Zeitlinger; 1991:185–214.

20. Gold JM, Hermann BP, Wyler A, Randolph C, Goldberg TE, Weinberger DR. Schizophrenia and temporal lobe epilepsy: a neuropsychological study. Arch Gen Psychiatry 1994;51:265–272.

21. Gold JM, Randolph C, Carpenter CJ, Goldberg TE, Weinberger DR. Forms of memory failure in schizophrenia. J Abnorm Psychol 1992;101:487–494.

22. Gold JM, Randolph C, Carpenter CJ, Goldberg TE, Weinberger DR. The performance of patients with schizophrenia on the Wechsler Memory Scale-Revised. Clin Neuropsychol 1992;6:367–373.

23. Goldberg TE, Berman KF, Mohr E, Weinberger DR. Regional cerebral blood flow and cognitive function in Huntington's disease and schizophrenia. Arch Neurol 1990;47:418–422.

24. Goldberg TE, Bigelow LB, Kleinman JE, Daniel DG, Weinberger DR. Effects of the coadministration of amphetamine and haloperidol on the affect, motor behavior, and cognition of patients with schizophrenia. Am J Psychiatry 1991;148:78–84.

25. Goldberg TE, Gold JM, Greenberg R, et al. Contrasts between patients with affective disorder and patients with schizophrenia on a neuropsychological screening battery. Am J Psychiatry 1993; 150:1355–1362.

26. Goldberg TE, Hyde TM, Kleinman JE, Weinberger DR. Course of schizophrenia: neuropsychological evidence for a static encephalopathy. Schiz Bull 1993;19:797–804.

27. Goldberg TE, Greenberg R, Griffin S, et al. The impact of clozapine on cognition and psychiatric symptoms in patients with schizophrenia. Br J Psychiatry 1993;162:43–48.

28. Goldberg TE, Ragland DR, Gold J, Bigelow LB, Torrey EF, Weinberger DR. Neuropsychological assessment of monozygotic twins discordant for schizophrenia. Arch Gen Psychiatry 1990;47:1066–1072.

29. Goldberg TE, Torrey EF, Berman KB, Weinberger DR. Relations between neuropsychological performance and brain morphological and physiological measures in monozygotic twins discordant for schizophrenia: use of an intrapair difference method. Psychiatry Res Neuroimag 1994;55:51–61.

30. Goldberg TE, Torrey EF, Gold JM, Ragland JD, Bigelow LB, Weinberger DR. Learning and memory in monozygotic twins discordant for schizophrenia. Psychol Med 1993;23:71–85.

31. Goldberg TE, Torrey EF, Gold JM, Ragland JD, Taylor E, Weinberger DR. Risk of cognitive impairment in monozygotic twins concordant and discordant for schizophrenia. Schiz Res [in press].

32. Goldberg TE, Weinberger DR. Schizophrenia, training paradigms, and the Wisconsin Card Sorting Test redux. Schiz Res 1994; 11:291–296.

33. Goldstein G, Zubin J. Neuropsychological differences between young and old schizophrenics with and without associated neurological dysfunction. Schiz Res 1990;3:117–126.

34. Gourovitch M, Goldberg TE, Weinberger DR. Differential verbal fluency deficits in schizophrenic patients as compared to normal controls. Schiz Res 1993;9:175–176.

35. Hagger C, Buckley P, Kenny JT, et al. Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine. Biol Psychiatry 1993;34:702–712.

36. Heaton RK, Crowley TJ. Effects of psychiatric disorders and their somatic treatment on neuropsychological test results. In: Filskov SB, Boll TJ, eds. Handbook of clinical neuropsychology. New York: John Wiley; 1981:481–525.

37. Hoff AL, Riordan H, O'Donnell DW, Morris L, DeLisi LE. Neuropsychological functioning of first-episode schizophreniform patients. Am J Psychiatry 1992;149:898–903.

38. Hunt JMcV, Cofer CN. Psychological deficit. In: Hunt JMcV (ed.) Personality and the behavior disorders. New York: Ronald Press; 1944.

39. Hurt SW, Holzman PS, Davis JM. Thought disorder: the measurement of its changes. Arch Gen Psychiatry 1983;40:1281–1285.

40. Hyde TM, Nawroz S, Goldberg TE, et al. Is there cognitive decline in schizophrenia? Results from a cross-sectional study. Br J Psychiatry [in press].

41. Kane J, Honigfeld G, Singer J, et al. Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988;45:789–796.

42. Kay S, Lindenmayer J-P. Stability of psychopathology dimensions in chronic schizophrenia: Response to clozapine treatment. Compr Psychiatry 1991;32:28–35.

43. Klonoff H, Hutton GH, Fibiger CH. Neuropsychological patterns in chronic schizophrenia. J Nerv Ment Dis 1970;150:291–300.

44. Kolb B, Whishaw IQ. Performance of schizophrenic patients on tests sensitive to left or right frontal temporal, and parietal function in neurologic patients. J Nerv Ment Dis 1983;171:435–443.

45. Kraepelin E. Dementia praecox and paraphrenia. Melbourne, FL: Robert E. Krieger, 1971. Robertson GM, ed. (original published in 1919).

46. Levy DL, Holzman PS, Matthysse S, Mendell NR. Eye tracking dysfunction and schizophrenia: a critical perspective. Schiz Bull 1993;19:461–536.

47. Liddle PF. Schizophrenic syndromes, cognitive performance and neurological dysfunction. Psychol Med 1987;17:49–57.

48. Malec J. Neuropsychological assessment of schizophrenia versus brain damage: a review. J Nerv Ment Dis 1978;166:507.

49. Malenka RC, Angel RW, Thiemann S, Weitz CJ, Berger PA. Central error-correcting behavior in schizophrenia and depression. Biol Psychiatry 1986;21:263–273.

50. Manschreck TC, Maher BA, Milavetz JJ, Ames D, Weisstein CC, Schneyer ML. Semantic priming in thought disordered schizophrenic patients. Schiz Res 1988;1:61–66.

51. Manschreck TC, Maher BA, Rosenthal JE, Berner J. Reduced primacy and related features in schizophrenia. Schiz Res 1991;5:35–41.

52. Medalia A, Gold JM, Merriam A. The effects of neuroleptics on neuropsychological test results of schizophrenics. Arch Clin Neuropsychol 1988;3:249–271.

53. Miller R. Schizophrenia as a progressive disorder relations to EEG, CT, neuropathological and other evidence. Progress Neurobiol 1989;33:17–44.

54. Mirsky AF. Research on schizophrenia in the NIMH Laboratory of Psychology and Psychopathology, 1954–1987. Schiz Bull 1988; 14:151–156.

55. Nuechterlein KH. Converging evidence for vigilance deficit as a vulnerability indicator for schizophrenic disorders. In: Alpert M, ed. Controversies in schizophrenia. New York: Guilford Press; 1985:175–198.

56. Oltmanns TF, Ohayon J, Nezle JM. The effect of medication and diagnostic criteria on distractibility in schizophrenia. J Psychiatric Res 1979;14:81–91.

57. Park S, Holzman PS. Schizophrenics show spatial working memory deficits. Arch Gen Psychiatry 1992;49:975–982.

58. Perlick D, Mattis S, Stasny P, Teresi J. Neuropsychological discriminators of long-term inpatient or outpatient status in chronic schizophrenia. J Neuropsychiatry Clin Neurosci 1992;4:428–434.

59. Rapaport D, Gill M, Schafer R. Diagnostic psychological testing. Chicago: Year Book Publishers, 1945/46.

60. Rausch MA, Prescott TE, DeWolfe AS. Schizophrenic and aphasic language: discriminable or not? J Consult Clin Psychol 1980; 48:63–70.

61. Saykin JA, Gur RC, Gur RE, et al. Neuropsychological function in schizophrenia: selective impairment in memory and learning. Arch Gen Psychiatry 1991;48:618–624.

62. Schwartz BL, Rosse RB, Deutsch SI. Limits of the processing view in accounting for dissociations among memory measures in a clinical population. Memory Cognition 1993;21:63–72.

63. Schwartzman AE, Douglas VI. Intellectual loss in schizophrenia part II. Can J Psychol 1962;16:161–168.

64. Seidman LJ, Pepple JR, Faraone SV, et al. Neuropsychological performance in chronic schizophrenia in response to neuroleptic dose reduction. Biol Psychiatry 1993;33:575–584.

65. Serper MR, Bergman RL, Harvey PD. Medication may be required for the development of automatic information processing in schizophrenia. Psychiatry Res 1990;32:281–288.

66. Shakow D. Adaptation in schizophrenia: the theory of segmental set. New York: John Wiley; 1979.

67. Shallice T, Burgess PW, Frith CD. Can the neuropsychological case-study approach be applied to schizophrenia? Psychol Med 1991;21:661–673.

68. Shelton RC, Weinberger DR. X-ray computerized tomography studies in schizophrenia: a review and synthesis. In: Nasrallah HA, Weinberger DR, eds. Handbook of schizophrenia. Amsterdam: Elsevier; 1986:207–250.

69. Singh J, Knight RT, Rosenlicht N, Kotun JM, Beckley DJ, Woods DL. Abnormal premovement brain potentials in schizophrenia. Schiz Res 1992;8:31–41.

70. Spohn HE, Strauss ME. Relation of neuroleptic and anticholinergic medication to cognitive function in schizophrenia. J Abnorm Psychol 1989;98:367–380.

71. Suddath RL, Christison GW, Torrey EF, Casanova MF, Weinberger DR. Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia. New Engl J Med 1990;22:789–794.

72. Sullivan EV, Mathalon DH, Zipursky RB, Kersteen-Tucker Z, Knight RT, Pfefferbaum A. Factors of the Wisconsin Card Sorting Test as measures of frontal-lobe function in schizophrenia and in chronic alcoholism. Psychiatry Res 1992;46:175–199.

73. Torrey EF, Bowler AE, Taylor EH, Gottesman II. Schizophrenia and manic-depressive disorder. New York: Basic Books; 1994.

74. Townes BD, Martin DC, Nelson D, Prosser R, Pepping M, Maxwell J. Neurobehavioral approach to classification of psychiatric patients using a competency model. J Consult Clin Psychol 1985;53:33–42.

75. Vrtunski PB, Simpson DM, Weiss KM, Davis GC. Abnormalities of fine motor control in schizophrenia. Psychiatry Res 1986; 18:275–284.

76. Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 1987;44:660–669.

77. Weinberger DR, Berman KF, Zec RF. Psychologic dysfunction of dorsolateral prefrontal cortex in schizophrenia: I. Regional cerebral blood flow evidence. Arch Gen Psychiatry 1986;43:114–124.